1. McQuade, R.M.; Stojanovska, V.; Donald, E.; Abalo, R.; Bornstein, J.C.; Nurgali, K. Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil. Neurogastroenterol. Motil. 2016, 28, 1861–1875. [CrossRef]
2. Posner, M.R.; Hershock, D.M.; Blajman, C.R.; Mickiewicz, E.; Winquist, E.; Gorbounova, V.; Tjulandin, S.; Shin, D.M.; Cullen, K.; Ervin, T.J.; et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N. Engl. J. Med. 2007, 357, 1705–1715. [CrossRef]
3. Wickham, R.S.; Rehwaldt, M.; Kefer, C.; Shott, S.; Abbas, K.; Glynn-Tucker, E.; Potter, C.; Blendowski, C. Taste changes experienced by patients receiving chemotherapy. Oncol. Nurs. Forum 1999, 26, 697–706.
4. Gamper, E.M.; Giesinger, J.M.; Oberguggenberger, A.; Kemmler, G.; Wintner, L.M.; Gattringer, K.; Sperner-Unterweger, B.; Holzner, B.; Zabernigg, A. Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: Prevalence, course of severity, and quality of life correlates. Acta Oncol. 2012, 51, 490–496. [CrossRef]
5. Berteretche, M.V.; Dalix, A.M.; d’Ornano, A.M.C.; Bellisle, F.; Khayat, D.; Faurion, A. Decreased taste sensitivity in cancer patients under chemotherapy. Support. Care Cancer 2004, 12, 571–576. [CrossRef]
6. Comeau, T.B.; Epstein, J.B.; Migas, C. Taste and smell dysfunction in patients receiving chemotherapy: A review of current knowledge. Support. Care Cancer 2001, 9, 575–580. [CrossRef]
7. Epstein, J.B.; Phillips, N.; Parry, J.; Epstein, M.S.; Nevill, T.; Stevenson-Moore, P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2002, 30, 785–792. [CrossRef]
8. Spotten, L.E.; Corish, C.A.; Lorton, C.M.; Ui Dhuibhir, P.M.; O’Donoghue, N.C.; O’Connor, B.; Walsh, T.D. Subjective and objective taste and smell changes in cancer. Ann. Oncol. 2017, 28, 969–984. [CrossRef]
9. Murtaza, B.; Hichami, A.; Khan, A.S.; Ghiringhelli, F.; Khan, N.A. Alteration in taste perception in cancer: Causes and strategies of treatment. Front. Physiol. 2017, 8, 134. [CrossRef]
10. Lindemann, B. Receptors and transduction in taste. Nature 2001, 413, 219–225. [CrossRef]
11. Tu, Y.H.; Cooper, A.J.; Teng, B.; Chang, R.B.; Artiga, D.J.; Turner, H.N.; Mulhall, E.M.; Ye, W.; Smith, A.D.; Liman, E.R. An evolutionarily conserved gene family encodes proton-selective ion channels. Science 2018, 359, 1047–1050. [CrossRef]
12. Shigemura, N.; Ninomiya, Y. Recent advances in molecular mechanisms of taste signaling and modifying. Int. Rev. Cell Mol. Biol. 2016, 323, 71–106. [CrossRef]
13. Perea-Martinez, I.; Nagai, T.; Chaudhari, N. Functional cell types in taste buds have distinct longevities. PLoS ONE 2013, 8, 1–9. [CrossRef]
14. Mahood, D.J.; Dose, A.M.; Loprinzi, C.L.; Veeder, M.H.; Athmann, L.M.; Therneau, T.M.; Sorensen, J.M.; Gainey, D.K.; Mailliard, J.A.; Gusa, N.L.; et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J. Clin. Oncol. 1991, 9, 449–452. [CrossRef]
15. Davidson, W.; Teleni, L.; Muller, J.; Ferguson, M.; McCarthy, A.L.; Vick, J.; Isenring, E. Malnutrition and chemotherapy-induced nausea and vomiting: Implications for practice. Oncol. Nurs. Forum 2012, 39, E340–E345. [CrossRef]
16. Kavoi, B.M.; Plendl, J.; Makanya, A.N.; Ochieng, S.; Kiama, S.G. Effects of anticancer drug docetaxel on the structure and function of the rabbit olfactory mucosa. Tissue Cell 2014, 46, 213–224. [CrossRef]
17. Zhang, S.; Liu, Y.; Xiang, D.; Yang, J.; Liu, D.; Ren, X.; Zhang, C. Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury. Biomed. Pharmacother. 2018, 106, 910–916. [CrossRef]
18. Bozec, A.; Sudaka, A.; Etienne-Grimaldi, M.-C.; Brunstein, M.-C.; Fischel, J.-L.; Milano, G. Antitumor activity of cetuximab associated with the taxotere–cisplatin–fluorouracil (TPF) combination on an orthotopic head and neck cancer model. Oral Oncol. 2011, 47, 940–945. [CrossRef]
19. Shimada, I.S.; Peterson, B.M.; Spees, J.L. Isolation of locally derived stem/progenitor cells from the peri-infarct area that do not migrate from the lateral ventricle after cortical stroke. Stroke 2010, 41, e552–e560. [CrossRef]
20. Miura, H.; Kato, H.; Kusakabe, Y.; Tagami, M.; Miura-Ohnuma, J.; Ninomiya, Y.; Hino, A. A strong nerve dependence of Sonic hedgehog expression in basal cells in mouse taste bud and an autonomous transcriptional control of genes in differentiated taste cells. Chem. Senses 2004, 29, 823–831. [CrossRef]
21. Vermorken, J.B.; Remenar, E.; van Herpen, C.; Gorlia, T.; Mesia, R.; Degardin, M.; Stewart, J.S.; Jelic, S.; Betka, J.; Preiss, J.H.; et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N. Engl. J. Med. 2007, 357, 1695–1704. [CrossRef]
22. Hall, J.M.; Bell, M.L.; Finger, T.E. Disruption of sonic hedgehog signaling alters growth and patterning of lingual taste papillae. Dev. Biol. 2003, 255, 263–277. [CrossRef]
23. Zabernigg, A.; Gamper, E.-M.; Giesinger, J.M.; Rumpold, G.; Kemmler, G.; Gattringer, K.; Sperner-Unterweger, B.; Holzner, B. Taste alterations in cancer patients receiving chemotherapy: A neglected side effect? Oncologist 2010, 15, 913–920. [CrossRef]
24. Cohen, J.; Wakefield, C.E.; Laing, D.C. Smell and taste disorders resulting from cancer and chemotherapy. Curr. Pharm. Des. 2016, 22, 2253–2263. [CrossRef]
25. Turcott, J.G.; Juárez-Hernández, E.; de la Torre-Vallejo, M.; Sánchez-Lara, K.; Luvian-Morales, J.; Arrieta, O. Value: Changes in the detection and recognition thresholds of three basic tastes in lung cancer patients receiving cisplatin and paclitaxel and its association with nutritional and quality of life parameters. Nutr. Cancer 2016, 68, 241–249. [CrossRef]
26. Ponticelli, E.; Clari, M.; Frigerio, S.; de Clemente, A.; Bergese, I.; Scavino, E.; Bernardini, A.; Sacerdote, C. Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross-sectional study. Eur. J. Cancer Care 2017, 26, e12633. [CrossRef]
27. Rha, S.Y.; Lee, J. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life. Support. Care Cancer 2017, 25, 1519–1527. [CrossRef]
28. IJpma, I.; Renken, R.J.; Gietema, J.A.; Slart, R.H.J.A.; Mensink, M.G.J.; Lefrandt, J.D.; Ter Horst, G.J.; Reyners, A.K.L. Changes in taste and smell function, dietary intake, food preference, and body composition in testicular cancer patients treated with cisplatin-based chemotherapy. Clin. Nutr. 2017, 36, 1642–1648. [CrossRef]
29. Bernhardson, B.M.; Tishelman, C.; Rutqvist, L.E. Chemosensory changes experienced by patients undergoing cancer chemotherapy: A qualitative interview study. J. Pain Symptom Manag. 2007, 34, 403–412. [CrossRef]
30. Bernhardson, B.M.; Tishelman, C.; Rutqvist, L.E. Self-reported taste and smell changes during cancer chemotherapy. Support. Care Cancer 2008, 16, 275–283. [CrossRef]
31. Steinbach, S.; Hundt, W.; Schmalfeldt, B.; Böhner, C.; Berktold, S.; Wolf, P.; Harbeck, N. Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients. Arch. Gynecol. Obstet. 2012, 286, 473–480. [CrossRef] [PubMed]
32. Boltong, A.; Aranda, S.; Keast, R.; Wynne, R.; Francis, P.A.; Chirgwin, J.; Gough, K. A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes. PLoS ONE 2014, 9, e103512. [CrossRef] [PubMed]
33. Lehrer, M.S.; Sun, T.T.; Lavker, R.M. Strategies of epithelial repair: Modulation of stem cell and transit amplifying cell proliferation. J. Cell Sci. 1998, 111, 2867–2875. [PubMed]
34. Nguyen, H.M.; Reyland, M.E.; Barlow, L.A. Mechanisms of taste bud cell loss after head and neck irradiation. J. Neurosci. 2012, 32, 3474–3484. [CrossRef]
35. Huang, A.L.; Chen, X.; Hoon, M.A.; Chandrashekar, J.; Guo, W.; Tränkner, D.; Ryba, N.J.P.; Zuker, C.S. The cells and logic for mammalian sour taste detection. Nature 2006, 442, 934–938. [CrossRef]
36. Lossow, K.; Hermans-Borgmeyer, I.; Behrens, M.; Meyerhof, W. Genetic labeling of Car4-expressing cells reveals subpopulations of type III taste cells. Chem. Senses 2017, 42, 747–758. [CrossRef]
37. Mukherjee, N.; Pal Choudhuri, S.; Delay, R.J.; Delay, E.R. Cellular mechanisms of cyclophosphamide-induced taste loss in mice. PLoS ONE 2017, 12, e0185473. [CrossRef]
38. Mukherjee, N.; Carroll, B.L.; Spees, J.L.; Delay, E.R. Pre-Treatment with amifostine protects against cyclophosphamide-induced disruption of taste in mice. PLoS ONE 2013, 8. [CrossRef]
39. Delay, E.R.; Socia, S.H.; Girardin, J.L.; Jewkes, B.C.; King, J.H.; Delay, R.J. Cyclophosphamide and the taste system: Effects of dose fractionation and amifostine on taste cell renewal. PLoS ONE 2019, 14, 1–23. [CrossRef]
40. Liu, H.X.; MacCallum, D.K.; Edwards, C.; Gaffield, W.; Mistretta, C.M. Sonic hedgehog exerts distinct, stage-specific effects on tongue and taste papilla development. Dev. Biol. 2004, 276, 280–300. [CrossRef]
41. Yang, H.; Cong, W.N.; Yoon, J.S.; Egan, J.M. Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds. Cancer Med. 2015, 4, 245–252. [CrossRef] [PubMed]
42. Kumari, A.; Ermilov, A.N.; Grachtchouk, M.; Dlugosz, A.A.; Allen, B.L.; Bradley, R.M.; Mistretta, C.M. Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib. Proc. Natl. Acad. Sci. USA 2017, 114, E10369–E10378. [CrossRef] [PubMed]
43. Yee, K.K.; Li, Y.; Redding, K.M.; Iwatsuki, K.; Margolskee, R.F.; Jiang, P. Lgr5-EGFP marks taste bud stem/progenitor cells in posterior tongue. Stem Cells 2013, 31, 992–1000. [CrossRef] [PubMed]
44. Matsumoto, I.; Ohmoto, M.; Narukawa, M.; Yoshihara, Y.; Abe, K. Skn-1a (Pou2f3) specifies taste receptor cell lineage. Nat. Neurosci. 2011, 14, 685–687. [CrossRef]
45. Soares, P.M.G.; Mota, J.M.S.C.; Gomes, A.S.; Oliveira, R.B.; Assreuy, A.M.S.; Brito, G.A.C.; Santos, A.A.; Ribeiro, R.A.; Souza, M.H.L.P. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother. Pharmacol. 2008, 63, 91–98. [CrossRef]
46. Sato, T.; Vries, R.G.; Snippert, H.J.; van de Wetering, M.; Barker, N.; Stange, D.E.; van Es, J.H.; Abo, A.; Kujala, P.; Peters, P.J.; et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459, 262–265. [CrossRef]
47. Katranci, N.; Ovayolu, N.; Ovayolu, O.; Sevinc, A. Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy—A randomized controlled trial. Eur. J. Oncol. Nurs. 2012, 16, 339–344. [CrossRef]
48. Vokurka, S.; Chvojkova, I.; Svoboda, T.; Brandejsova, R.; Jungova, A.; Bystricka, E.; Jindra, P. The impact of oral cryotherapy and oral and gastrointestinal mucositis after autologous stem cell transplantation. Eur. J. Oncol. Nurs. 2014, 18, 228–229. [CrossRef]
49. Walladbegi, J.; Smith, S.A.; Grayson, A.K.; Murdoch, C.; Jontell, M.; Colley, H.E. Cooling of the oral mucosa to prevent adverse effects of chemotherapeutic agents: An in vitro study. J. Oral Pathol. Med. 2018, 47, 477–483. [CrossRef]
50. Bauman, B.; Mick, R.; Martinez, E.; Lawless, T.M.; Zinck, L.; Sinclair, P.; Fuhrer, M.; O’Hara, M.; Schneider, C.J.; O’Dwyer, P.; et al. Efficacy of oral cryotherapy during oxaliplatin infusion in preventing oral thermal hyperalgesia: A randomized trial. Natl. Compr. Canc. Netw. 2019, 17, 358–364. [CrossRef]
51. Hanai, A.; Ishiguro, H.; Sozu, T.; Tsuda, M.; Yano, I.; Nakagawa, T.; Imai, S.; Hamabe, Y.; Toi, M.; Arai, H.; et al. Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: Prospective self-controlled trial. J. Natl. Cancer Inst. 2018, 110, 141–148. [CrossRef] [PubMed]
52. Yoshida, R.; Ohkuri, T.; Jyotaki, M.; Yasuo, T.; Horio, N.; Yasumatsu, K.; Sanematsu, K.; Shigemura, N.; Yamamoto, T.; Margolskee, R.F.; et al. Endocannabinoids selectively enhance sweet taste. Proc. Natl. Acad. Sci. USA 2010, 107, 935–939. [CrossRef] [PubMed]
論文の公開元へ
